Comparison of the pharmacokinetics and sedative effects of Zenalpha (medetomidine and vatinoxan) administered intramuscularly and oral transmucosally in dogs
American Journal of Veterinary Research · 04.11.2026 · 1-10
DOI: 10.2460/ajvr.26.02.0080 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Veterinary Research, erschienen am 04.11.2026. Verfasst von Andrew W Lathan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, TN. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To evaluate the sedative effects and pharmacokinetic profile of medetomidine and vatinoxan (Zenalpha) administered via the oral transmucosal (OTM) route. We hypothesized that sedation scores obtained from Zenalpha OTM (ZOTM) would not differ from Zenalpha IM (ZIM).
Methods
Dogs received 20 µg/kg ZIM or 80 µg/kg ZOTM. Sedation, anxiolytic, and handling scores were collected at 0, 15, 30, 30, 45, 60, 75, 90, 120, 150, and 180 minutes after administration of Zenalpha. Normality was tested using the Shapiro-Wilk test, and data were presented as median and range. Physiologic data were collected at 0, 5, 10, 15, 30, 45, 60, 90, 120, 240, 360, and 480 minutes. Plasma samples were collected at 0, 3, 5, 8, 8, 10, 15, 30, 45, 60, 90, 120, 240, 360, 480, 720, and 1,440 minutes and analyzed for concentration of medetomidine and vatinoxan using LC-MS-MS.
Results
8 healthy adult Beagles participated in this study. Dogs in ZIM and ZOTM showed significant increases in sedation, anxiolysis, and handling scores compared to baselines. Medetomidine OTM was associated with a time to maximum concentration and relative bioavailability of 86 minutes (6 minutes ZIM) and 26.4%, respectively. Vatinoxan OTM was associated with a time to maximum concentration and relative bioavailability of 216 minutes (15 minutes ZIM) and 55.2%, respectively.
Conclusions
ZOTM (80 μg/kg) provided effective sedation, anxiolysis, and improved handling in healthy dogs comparable to ZIM (20 μg/kg) administration. Clinical Relevance Zenalpha administered OTM, at higher doses, may provide an attractive alternative to IM injection to achieve similar sedation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, TN.
- Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, TN.
- Office of Information Technology, University of Tennessee, Knoxville, TN.
- Department of Molecular Biosciences, School of Veterinary Medicine, University of California-Davis, Davis, CA.
ORCID-Profile: Andrew W Lathan, Christopher K Smith, Stephanie A Kleine, Joe S Smith, Zenithson Ng, Chiara E Hampton, Genevieve Bussieres, Reza Seddighi
Zitieren
APA
Lathan, A. W., Smith, C. K., Kleine, S. A., Smith, J. S., Ng, Z., Hampton, C. E., Bussieres, G., Sun, X., Rust, M. R., Knych, H., & Seddighi, R. (2026). Comparison of the pharmacokinetics and sedative effects of Zenalpha (medetomidine and vatinoxan) administered intramuscularly and oral transmucosally in dogs. American Journal of Veterinary Research, 1-10. https://doi.org/10.2460/ajvr.26.02.0080
Vancouver
Lathan AW, Smith CK, Kleine SA, Smith JS, Ng Z, Hampton CE, et al. Comparison of the pharmacokinetics and sedative effects of Zenalpha (medetomidine and vatinoxan) administered intramuscularly and oral transmucosally in dogs. American Journal of Veterinary Research. 2026:1-10. doi:10.2460/ajvr.26.02.0080
BibTeX
@article{Lathan2026,
author = {Lathan, Andrew W and Smith, Christopher K and Kleine, Stephanie A and Smith, Joe S and Ng, Zenithson and Hampton, Chiara E and Bussieres, Genevieve and Sun, Xiaocun and Rust, Mitchell R and Knych, Heather and Seddighi, Reza},
title = {Comparison of the pharmacokinetics and sedative effects of Zenalpha (medetomidine and vatinoxan) administered intramuscularly and oral transmucosally in dogs},
journal = {American Journal of Veterinary Research},
year = {2026},
pages = {1--10},
doi = {10.2460/ajvr.26.02.0080}
}
EUVIMED